Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant fallopian tube epithelia, with comparison to ovarian carcinomas

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 5, 2005, Pages 651-654

  Kalir, Tamara ^a   Rahaman, Jamal ^a   Hagopian, George ^a   Demopoulos, Rita ^b   Cohen, Carmel ^a   Burstein, David E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; BRCA1 PROTEIN; DIAMINOBENZIDINE; GLUCOSE TRANSPORTER 1; STREPTAVIDIN;

ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; OVARY CARCINOMA; PERINEURIUM; SALPINGITIS; UTERINE TUBE CARCINOMA;

ADENOCARCINOMA; EPITHELIAL CELLS; FALLOPIAN TUBE NEOPLASMS; FALLOPIAN TUBES; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MONOSACCHARIDE TRANSPORT PROTEINS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 18144423994     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wang BW, Kalir T, Sabo E, Sherman DE, Cohen C, Burstein DE. Immunohistochemical staining of GLUT1 in benign, hyperplastic and malignant endometrial epithelia. Cancer. 2000;88:2774-2781.
2. Kalir T, Wang BY, Goldfischer M, et al. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia. Cancer. 2002;94:1078-1082.
3. Mellanen P, Minn H, Grenman R, Harkonen P. Expression of glucose transporters in head-and-neck tumors. Int J Cancer. 1994;56:622-629.
4. Nagase Y, Takata K, Moriyama N, Aso Y, Murakami T, Hirano H. Immunohistochemical localization of glucose transporters in human renal cell carcinoma. J Urol. 1995;153:798-801.
5. Younes M, Brown RW, Mody DR, Fernandez L, Laucirica R. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res. 1995;5:2895-2898.
6. Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res. 1996;56:1164-1167.
7. Younes M, Lechago LV, Lechago J. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin Cancer Res. 1996;2:1151-1154.
8. Haber RS, Weiser KR, Pritsker A, Reder I, Burstein DE. GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid. 1997;7:363-367.
9. Younes M, Brown RW, Stephenson M, Gondo M, Cagle PT. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer. 1997;80:1046-1051.
10. Haber RS, Rathan A, Weiser KR, et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer. 1998;83:34-40.
11. Younes M, Juarez D, Lechago LV, Lerner SP. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Anticancer Res. 2001;21:575-578.
12. Kawamura T, Kusakabe T, Sugino T, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer. 2001;92:634-641.
13. Kim YW, Park YK, Yoon TY, Lee SM. Expression of the GLUT1 glucose transporter in gallbladder carcinomas. Hepatogastroenterology. 2002;49:907-911.
14. Paley PJ, Swisher EM, Garcia RL, et al. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncot. 2001;80:176-180.
15. Aziz S, Kuperstein G, Rosen B, et al. A genetic epidemiological study of carcinoma of the fallopian tube. Gynecol Oncol. 2001;80:341-345.
16. Colgan TJ, Murphy J, Cole DE, Narod S, Rosen B. Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol. 2001;25:1283-1289.
17. Hartley A, Rollason T, Spooner D. Clear cell carcinoma of the fimbria of the fallopian tube in a BRCA1 carrier undergoing prophylactic surgery. Clin Oncol (R Coll Radiol). 2000;12:58-59.
18. Shaw PA, Rouzbahman M, Murphy JM, Rosen B, Begley H. Mucosal epithelial proliferation and p53 overexpression of fallopian tube epithelium in women with mutations of BRCA1 or BRCA2 [abstract]. Mod Pathol. 2004;17:214A.
19. Demopoulos RI, Aronov R, Mesia A. Clues to the pathogenesis of fallopian tube carcinoma: a morphological and immunohistochemical case control study. Int J Gynecol Pathol. 2001;20:128-132.
20. Wiskind AK, Dudley AG, Majmudar B, Masterson KC. Primary fallopian tube carcinoma with coexistent tuberculous salpingitis: a case report. J Med Assoc Ga. 1992;81:77-81.
21. Kalogirou D, Mantzavinos T, Zourlas PA, Deligiorgi E. Primary adenocarcinoma of the fallopian tube with tuberculosis. Eur J Gynecol Oncol. 1989;10:307-309.
22. Berek JS, Bast RC. Ovarian cancer. In: Kufe DW, Pollock RE, Ralph R, et al, eds. Cancer Medicine. 6th ed. Hamilton, Ontario: BC Decker Inc; 2003:1831-1861.
23. Wheeler JE. Diseases of the fallopian tube. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 4th ed. New York, NY: Springer-Verlag; 1994:547.
24. Di Re E, Grosso G, Raspagliesi F, Baiocchi G. Fallopian tube cancer: incidence and role of lymphatic spread. Gynecol Oncol. 1996;62:199-202.
25. Cohen CJ, Rahaman J. Fallopian tube cancer. In: Kufe DW, Pollock RE, Weichselbaum RR, et al, eds. Cancer Medicine. 6th ed. Hamilton, Ontario: BC Decker Inc; 2003:1825-1829.
26. Rosen AC, Klein M, Hafner E, Lahousen M, Graf AH, Reiner A. Management and prognosis of primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Gynecol Obstet Invest. 1999;47:45-51.
27. Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr, Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA. 1996;93:10595-10599.
28. Burstein DE, Reder I, Weiser K, Tong T, Pritsker A, Haber RS. GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions. Mod Pathol. 1998;11:392-396.